BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26165750)

  • 1. Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviors in normal and autistic adolescents.
    Frenssen F; Croonenberghs J; Van den Steene H; Maes M
    Life Sci; 2015 Sep; 136():157-62. PubMed ID: 26165750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety.
    Maes M; Goossens F; Lin A; De Meester I; Van Gastel A; Scharpé S
    Psychoneuroendocrinology; 1998 Jul; 23(5):485-95. PubMed ID: 9802123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia.
    Maes M; Libbrecht I; Van Hunsel F; Lin AH; Bonaccorso S; Goossens F; De Meester I; De Clerck L; Biondi M; Scharpe S; Janca A
    Psychol Med; 1998 Jul; 28(4):957-65. PubMed ID: 9723150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of dipeptidyl peptidase II, dipeptidyl peptidase IV, and prolyl endopeptidase in effusion from patients with serous otitis media.
    Rao AJ; Hagihara M; Nagatsu T; Yanagita N
    Biochem Med Metab Biol; 1990 Jun; 43(3):276-82. PubMed ID: 1974452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients.
    Van Gool AR; Van Ojik HH; Kruit WH; Mulder PG; Fekkes D; Bannink M; Scharpé S; Stoter G; Eggermont AM; Maes M; Verkerk R
    J Interferon Cytokine Res; 2004 Jul; 24(7):411-5. PubMed ID: 15296652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of peptidases in cultured cells from middle ear mucosa: prolyl endopeptidase is localized in fibroblasts and dipeptidyl peptidase IV and II in epithelial cells.
    Avasarala JR; Naoi M; Sasaki S; Ueda M; Saga S; Suzuki T; Yanagita N; Nagatsu T
    Biochem Med Metab Biol; 1991 Jun; 45(3):355-8. PubMed ID: 1675574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower activity of serum peptidases in abstinent alcohol-dependent patients.
    Maes M; Lin A; Bonaccorso S; Vandoolaeghe E; Song C; Goossens F; De Meester I; Degroote J; Neels H; Scharpé S; Janca A
    Alcohol; 1999 Jan; 17(1):1-6. PubMed ID: 9895030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects.
    Maes M; Scharpé S; De Meester I; Goossens P; Wauters A; Neels H; Verkerk R; De Meyer F; D'Hondt P; Peeters D
    Clin Chem; 1994 Sep; 40(9):1686-91. PubMed ID: 7915215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
    Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer HY
    Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.
    Vojdani A; Bazargan M; Vojdani E; Samadi J; Nourian AA; Eghbalieh N; Cooper EL
    Clin Diagn Lab Immunol; 2004 May; 11(3):515-24. PubMed ID: 15138176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders.
    Momeni N; Nordström BM; Horstmann V; Avarseji H; Sivberg BV
    BMC Psychiatry; 2005 Jun; 5():27. PubMed ID: 15932649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis.
    Kamori M; Hagihara M; Nagatsu T; Iwata H; Miura T
    Biochem Med Metab Biol; 1991 Apr; 45(2):154-60. PubMed ID: 1679339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia: diagnostic implications.
    Čulić O; Cordero MD; Žanić-Grubišić T; Somborac-Bačura A; Pučar LB; Detel D; Varljen J; Barišić K
    Clin Rheumatol; 2016 Oct; 35(10):2565-71. PubMed ID: 27527091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects.
    Nagatsu T
    J Neural Transm (Vienna); 2017 Jun; 124(6):739-744. PubMed ID: 27503084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.
    Wolke C; Teumer A; Endlich K; Endlich N; Rettig R; Stracke S; Fiene B; Aymanns S; Felix SB; Hannemann A; Lendeckel U
    Exp Biol Med (Maywood); 2017 Mar; 242(5):554-563. PubMed ID: 28038565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression.
    Deng J; Lamb JR; Mckeown AP; Miller S; Muglia P; Guest PC; Bahn S; Domenici E; Rahmoune H
    J Affect Disord; 2013 Nov; 151(2):667-672. PubMed ID: 23948634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.
    Maes M; Capuron L; Ravaud A; Gualde N; Bosmans E; Egyed B; Dantzer R; Neveu PJ
    Neuropsychopharmacology; 2001 Feb; 24(2):130-40. PubMed ID: 11120395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.
    Sun AL; Deng JT; Guan GJ; Chen SH; Liu YT; Cheng J; Li ZW; Zhuang XH; Sun FD; Deng HP
    Diab Vasc Dis Res; 2012 Oct; 9(4):301-8. PubMed ID: 22388283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (Prodipine).
    De Meester I; Belyaev A; Lambeir AM; De Meyer GR; Van Osselaer N; Haemers A; Scharpé S
    Biochem Pharmacol; 1997 Jul; 54(1):173-9. PubMed ID: 9296364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.